DexCom (DXCM)
(Delayed Data from NSDQ)
$70.05 USD
-0.97 (-1.37%)
Updated Aug 14, 2024 04:00 PM ET
Pre-Market: $70.30 +0.25 (0.36%) 8:42 AM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 401 - 415 ( 415 total )
Company: DexCom, Inc.
Industry: Medical - Products
INCREASED FDA SCRUTINY LEADING TO LONGER APPROVAL TIMES
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Financials Meet Expectations. SEVEN PLUS Demand Remains Strong and New Product Launches Anticipated.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Preview: We are at the Mid-Range of Consensus and Believe Our Estimates are Achievable.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
70TH ANNUALAMERICAN DIABETES ASSOCIATION MEETING CONFIRMS THESIS - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Life Sciences: Biopharmaceuticals / Biotechnology.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L